课题基金 / 基金详情

Chondrocyte DNA Double-Strand Breaks in the Pathogenesis of Osteoarthritis

Chondrocyte DNA Double-Strand Breaks in the Pathogenesis of Osteoarthritis
软骨细胞 DNA 双链断裂在骨关节炎发病机制中的作用
批准号:
10160787
负责人:
Jennifer Harrell Jonason
金额:
$32.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-05-07 至 2025-04-30

项目摘要

项目成果

Jennifer Harrell Jonason的其他基金

相似基金

相关文献

中文摘要
翻译
骨关节炎(OA)是最常见的关节炎形式,也是导致成人残疾的主要原因。虽然衰老是OA发生的重要危险因素,但在衰老背景下OA发生的分子机制尚不清楚。在这里,我们提出验证关节软骨细胞中的DNA DSBs促进细胞周期再进入的假设,并诱导STING下游的IKKBeta/NF-kappaB和IRF信号介导促炎分泌表型,导致软骨退变和周围关节组织炎症。我们发现IKKBeta/NF-kappaB信号在野生型小鼠的关节软骨细胞中随着年龄的增长而增加,并且在24个月时,这些小鼠的膝关节表型表现出OA的早期特征。我们还表明,年轻小鼠软骨细胞中持续的IKKBeta激活极大地加速了这种与年龄相关的OA表型的发生,这可能是通过促炎分泌程序对周围细胞的旁分泌作用,该程序由许多细胞因子、趋化因子、生长因子和MMPs组成,可以改变邻近细胞的增殖和活力,重塑软骨ECM,并启动先天免疫反应。已知DNA双链断裂(DSBs)可诱导IKKBeta/NF-kappaB信号传导,我们在此提供了老年小鼠关节软骨细胞中DNA双链断裂的证据。我们还提供了基因表达数据,显示IRF和干扰素信号是衰老关节软骨细胞中受影响最显著的途径。DNA dsb可以通过干扰素基因刺激因子(STING)诱导NF-kappaB和IRF信号。因此,我们假设STING可能位于NF-kappaB和IRF的上游,从而在dsb软骨细胞中产生促炎分泌表型。在本提案的第一个目标中,我们将使用AcanCreERT2/+测试软骨细胞特异性DNA dsb对软骨细胞功能和OA发展的影响;r26i - poi小鼠,在给予他莫昔芬后在软骨细胞中特异性产生dsb。我们将确定软骨细胞如何应对这种基因毒性应激,以及持续性dsb是否能够促进骨性关节炎。在第二个目标中,我们将使用体外细胞培养方法以及结合NF-kappaB和IRF内源性报告基因的体内STING敲除模型,测试STING是否特异性参与dsb诱导后IKKBeta/NF-kappaB和IRF信号的激活,以及年龄相关性OA的发病。这些研究的结果将为DNA DSBs对软骨细胞命运的影响以及衰老软骨细胞中NF-kappaB上游激活因子的身份提供有价值的见解,可能导致发现一种抑制OA软骨细胞中IKKBeta/NF-kappaB信号传导和炎症的新机制。
英文摘要
Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability in adults. While aging is an important risk factor for the development of OA, the molecular mechanisms responsible for OA in the context of aging remain unclear. Here, we propose to test the hypothesis that DNA DSBs in articular chondrocytes promote cell cycle re-entry and induce both IKKBeta/NF-kappaB and IRF signaling downstream of STING to mediate a pro-inflammatory secretory phenotype that leads to cartilage degeneration and inflammation in surrounding joint tissues. We show that IKKBeta/NF-kappaB signaling increases with age in the articular chondrocytes of wild type mice and that, by 24 months, these mice develop a knee joint phenotype exhibiting early hallmarks of OA. We also show that sustained IKKBeta activation in the chondrocytes of young mice greatly accelerates the onset of this age-related OA phenotype likely through paracrine actions on surrounding cells via a proinflammatory secretory program consisting of numerous cytokines, chemokines, growth factors, and MMPs that can alter proliferation and viability of neighboring cells, remodel the cartilage ECM, and initiate an innate immune response. DNA double-strand breaks (DSBs) are known to induce IKKBeta/NF-kappaB signaling and we provide evidence here of DNA DSBs in aged murine articular chondrocytes. We also provide gene expression data showing that IRF and Interferon signaling are among the most significantly affected pathways in aged articular chondrocytes. DNA DSBs can induce both NF-kappaB and IRF signaling through Stimulator of interferon genes, or STING. Thus, we hypothesize that STING may be upstream of both NF-kappaB and IRF to produce a proinflammatory secretory phenotype in chondrocytes with DSBs. In the first Aim of this proposal, we will test the effects of chondrocyte-specific DNA DSBs on chondrocyte function and OA development using AcanCreERT2/+; R26I-PpoI mice where DSBs are produced specifically in chondrocytes upon administration of tamoxifen. We will determine how chondrocytes respond to this genotoxic stress and also whether persistent DSBs are capable of promoting OA. In the second Aim, we will test whether STING is specifically involved in the activation of IKKBeta/NF-kappaB and IRF signaling following induction of DSBs and in the onset of age-related OA using in vitro cell culture methods as well as an in vivo STING knockout model in combination with NF-kappaB and IRF endogenous reporters. Results from these studies will provide valuable insight to the effects of DNA DSBs on chondrocyte fate and also on the identity of upstream activators of NF-kappaB in aged chondrocytes, potentially leading to the identification of a novel mechanism in which to inhibit IKKBeta/NF-kappaB signaling and inflammation in OA chondrocytes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chondrocyte DNA Double-Strand Breaks in the Pathogenesis of Osteoarthritis
  • 批准号:
    10624247
  • 项目类别:
  • 资助金额:
    $33.88万
  • 财政年份:
    2020
  • 负责人:
    Jennifer Harrell Jonason
  • 依托单位:
Chondrocyte DNA Double-Strand Breaks in the Pathogenesis of Osteoarthritis
  • 批准号:
    10401911
  • 项目类别:
  • 资助金额:
    $33.54万
  • 财政年份:
    2020
  • 负责人:
    Jennifer Harrell Jonason
  • 依托单位:
海外基金